June 8, 2020 / 5:53 PM / 2 months ago

BRIEF-Adial Pharmaceuticals And Biolab Sciences Enter Into Distribution Agreement For Covid-19 Antibody Tests

June 8 (Reuters) - Adial Pharmaceuticals Inc:

* ADIAL PHARMACEUTICALS AND BIOLAB SCIENCES ENTER INTO DISTRIBUTION AGREEMENT FOR COVID-19 ANTIBODY TESTS

* ADIAL PHARMACEUTICALS INC - ANTIBODY TESTING AVAILABLE FOR LANDMARK ONWARD PIVOTAL PHASE 3 TRIAL PARTICIPANTS

* ADIAL PHARMACEUTICALS - BIOLAB SCIENCES GRANTS ADIAL EXCLUSIVE RIGHTS TO SELL AND DISTRIBUTE RAPID RESULT COVID-19 ANTIBODY TESTS TO DESIGNATED CHANNEL PARTNERS Source text: [ID:bit.ly/2ASTI17] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below